• Published On : Jul-2017 |
  • Pages : 242 Pages |
  • Format :

1. Executive Summary
   1.1. Market Overview
   1.2. Market Analysis
   1.3. PMR Analysis and Recommendations
   1.4. Wheel of Fortune

2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy
   2.3. Regulatory Scenario

3. Human Papillomavirus (HPV) Testing Market Opportunity Analysis
   3.1. Macro-Economic Factors
   3.2. Opportunity Analysis

4. North America Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
   4.1. Introduction
   4.2. Key Regulations
   4.3. Regional Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Trends
   4.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        4.4.1. U.S.
        4.4.2. Canada
   4.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
        4.5.1. U.S.
        4.5.2. Canada
   4.6. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
        4.6.1. DNA-based Test
        4.6.2. RNA-based Test
   4.7. Market Size (US$ Mn) Forecast By Product, 2017–2025
        4.7.1. DNA-based Test
        4.7.2. RNA-based Test
   4.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
        4.8.1. Hospitals
        4.8.2. Clinics
        4.8.3. Diagnostic Centers
        4.8.4. Research Institutes
   4.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
        4.9.1. Hospitals
        4.9.2. Clinics
        4.9.3. Diagnostic Centers
        4.9.4. Research Institutes
   4.10. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
        4.10.1. Molecular Diagnostics
        4.10.2. Research Use
   4.11. Market Size (US$ Mn) Forecast By Applications, 2017–2025
        4.11.1. Molecular Diagnostics
        4.11.2. Research Use
   4.12. Drivers and Restraints: Impact Analysis
   4.13. Market Attractiveness Analysis
        4.13.1. By Country
        4.13.2. By Product
        4.13.3. By End User
        4.13.4. By Applications
   4.14. Key Representative Market Participants
   4.15. Market Presence (Intensity Map)

5. Latin America Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
   5.1. Introduction
   5.2. Key Regulations
   5.3. Regional Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Trends
   5.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        5.4.1. Brazil
        5.4.2. Mexico
        5.4.3. Argentina
        5.4.4. Rest of Latin America
   5.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
        5.5.1. Brazil
        5.5.2. Mexico
        5.5.3. Argentina
        5.5.4. Rest of Latin America
   5.6. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
        5.6.1. DNA-based Test
        5.6.2. RNA-based Test
   5.7. Market Size (US$ Mn) Forecast By Product, 2017–2025
        5.7.1. DNA-based Test
        5.7.2. RNA-based Test
   5.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
        5.8.1. Hospitals
        5.8.2. Clinics
        5.8.3. Diagnostic Centers
        5.8.4. Research Institutes
   5.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
        5.9.1. Hospitals
        5.9.2. Clinics
        5.9.3. Diagnostic Centers
        5.9.4. Research Institutes
   5.10. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
        5.10.1. Molecular Diagnostics
        5.10.2. Research Use
   5.11. Market Size (US$ Mn) Forecast By Applications, 2017–2025
        5.11.1. Molecular Diagnostics
        5.11.2. Research Use
   5.12. Drivers and Restraints: Impact Analysis
   5.13. Market Attractiveness Analysis
        5.13.1. By Country
        5.13.2. By Product
        5.13.3. By End User
        5.13.4. By Applications
   5.14. Key Representative Market Participants
   5.15. Market Presence (Intensity Map)

6. Europe Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
   6.1. Introduction
   6.2. Key Regulations
   6.3. Regional Market Dynamics
        6.3.1. Drivers
        6.3.2. Restraints
        6.3.3. Trends
   6.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        6.4.1. Germany
        6.4.2. France
        6.4.3. Russia
        6.4.4. Italy
        6.4.5. Spain
        6.4.6. U.K.
        6.4.7. Netherlands
        6.4.8. Rest of Europe
   6.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
        6.5.1. Germany
        6.5.2. France
        6.5.3. Russia
        6.5.4. Italy
        6.5.5. Spain
        6.5.6. U.K.
        6.5.7. Netherlands
        6.5.8. Rest of Europe
   6.6. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
        6.6.1. DNA-based Test
        6.6.2. RNA-based Test
   6.7. Market Size (US$ Mn) Forecast By Product, 2017–2025
        6.7.1. DNA-based Test
        6.7.2. RNA-based Test
   6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
        6.8.1. Hospitals
        6.8.2. Clinics
        6.8.3. Diagnostic Centers
        6.8.4. Research Institutes
   6.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
        6.9.1. Hospitals
        6.9.2. Clinics
        6.9.3. Diagnostic Centers
        6.9.4. Research Institutes
   6.10. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
        6.10.1. Molecular Diagnostics
        6.10.2. Research Use
   6.11. Market Size (US$ Mn) Forecast By Applications, 2017–2025
        6.11.1. Molecular Diagnostics
        6.11.2. Research Use
   6.12. Drivers and Restraints: Impact Analysis
   6.13. Market Attractiveness Analysis
        6.13.1. By Country
        6.13.2. By Product
        6.13.3. By End User
        6.13.4. By Applications
   6.14. Key Representative Market Participants
   6.15. Market Presence (Intensity Map)

7. Asia Pacific Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
   7.1. Introduction
   7.2. Key Regulations
   7.3. Regional Market Dynamics
        7.3.1. Drivers
        7.3.2. Restraints
        7.3.3. Trends
   7.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        7.4.1. China
        7.4.2. India
        7.4.3. Japan
        7.4.4. Australia and New Zealand
        7.4.5. Rest of Asia Pacific
   7.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
        7.5.1. China
        7.5.2. India
        7.5.3. Japan
        7.5.4. Australia and New Zealand
        7.5.5. Rest of Asia Pacific
   7.6. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
        7.6.1. DNA-based Test
        7.6.2. RNA-based Test
   7.7. Market Size (US$ Mn) Forecast By Product, 2017–2025
        7.7.1. DNA-based Test
        7.7.2. RNA-based Test
   7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
        7.8.1. Hospitals
        7.8.2. Clinics
        7.8.3. Diagnostic Centers
        7.8.4. Research Institutes
   7.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
        7.9.1. Hospitals
        7.9.2. Clinics
        7.9.3. Diagnostic Centers
        7.9.4. Research Institutes
   7.10. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
        7.10.1. Molecular Diagnostics
        7.10.2. Research Use
   7.11. Market Size (US$ Mn) Forecast By Applications, 2017–2025
        7.11.1. Molecular Diagnostics
        7.11.2. Research Use
   7.12. Drivers and Restraints: Impact Analysis
   7.13. Market Attractiveness Analysis
        7.13.1. By Country
        7.13.2. By Product
        7.13.3. By End User
        7.13.4. By Applications
   7.14. Key Representative Market Participants
   7.15. Market Presence (Intensity Map)

8. Middle East & Africa Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
   8.1. Introduction
   8.2. Key Regulations
   8.3. Regional Market Dynamics
        8.3.1. Drivers
        8.3.2. Restraints
        8.3.3. Trends
   8.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        8.4.1. GCC Countries
        8.4.2. South Africa
        8.4.3. Turkey
        8.4.4. Rest of MEA
   8.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
        8.5.1. GCC Countries
        8.5.2. South Africa
        8.5.3. Turkey
        8.5.4. Rest of MEA
   8.6. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
        8.6.1. DNA-based Test
        8.6.2. RNA-based Test
   8.7. Market Size (US$ Mn) Forecast By Product, 2017–2025
        8.7.1. DNA-based Test
        8.7.2. RNA-based Test
   8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
        8.8.1. Hospitals
        8.8.2. Clinics
        8.8.3. Diagnostic Centers
        8.8.4. Research Institutes
   8.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
        8.9.1. Hospitals
        8.9.2. Clinics
        8.9.3. Diagnostic Centers
        8.9.4. Research Institutes
   8.10. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
        8.10.1. Molecular Diagnostics
        8.10.2. Research Use
   8.11. Market Size (US$ Mn) Forecast By Applications, 2017–2025
        8.11.1. Molecular Diagnostics
        8.11.2. Research Use
   8.12. Drivers and Restraints: Impact Analysis
   8.13. Market Attractiveness Analysis
        8.13.1. By Country
        8.13.2. By Product
        8.13.3. By End User
        8.13.4. By Applications
   8.14. Key Representative Market Participants
   8.15. Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape
   11.1. Competition Dashboard
   11.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
        11.2.1. F. Hoffmann-La Roche Ltd.
        11.2.2. Agilent Technologies, Inc.
        11.2.3. Becton, Dickinson and Company
        11.2.4. Qiagen N.V.
        11.2.5. Thermo Fisher Scientific Inc.
        11.2.6. Abbott Laboratories
        11.2.7. Hologic Inc.
        11.2.8. Cepheid Inc.
        11.2.9. Seegene Inc.
        11.2.10. Takara Bio Inc.
        11.2.11. DaAn Gene Co., Ltd. of Sun Yat-Sen University
        11.2.12. Promega Corporation
        11.2.13. Greiner Bio-One International GmbH (Greiner Holding AG)
        11.2.14. Enzo Biochem Inc.
        11.2.15. Norgen Biotek Corp.
        11.2.16. DiagCor Bioscience Inc Ltd
        11.2.17. Hybribio Limited
        11.2.18. Zytovision GmbH
        11.2.19. Arbor Vita Corporation
        11.2.20. Medical & Biological Laboratories Co., Ltd
        11.2.21. Fujirebio Diagnostics, Inc.

12. Global Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Region
   12.1. Introduction/Key Findings
   12.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
        12.2.1. North America
        12.2.2. Latin America
        12.2.3. Europe
        12.2.4. Asia Pacific
        12.2.5. Middle East & Africa
   12.3. Market Size (US$ Mn) Forecast By Region, 2017–2025
        12.3.1. North America
        12.3.2. Latin America
        12.3.3. Europe
        12.3.4. Asia Pacific
        12.3.5. Middle East & Africa
   12.4. Market Attractiveness Analysis By Region

13. Global Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Product
   13.1. Introduction/Key Findings
   13.2. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
        13.2.1. DNA-based Test
        13.2.2. RNA-based Test
   13.3. Market Size (US$ Mn) and Forecast By Product, 2017–2025
        13.3.1. DNA-based Test
        13.3.2. RNA-based Test
   13.4. Market Attractiveness Analysis By Product

14. Global Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025, By End User
   14.1. Introduction/Key Findings
   14.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
        14.2.1. Hospitals
        14.2.2. Clinics
        14.2.3. Diagnostic Centers
        14.2.4. Research Institutes
   14.3. Market Size (US$ Mn) Forecast By End User, 2017–2025
        14.3.1. Hospitals
        14.3.2. Clinics
        14.3.3. Diagnostic Centers
        14.3.4. Research Institutes
   14.4. Market Attractiveness Analysis By End User

15. Global Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Applications
   15.1. Introduction/Key Findings
   15.2. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
        15.2.1. Molecular Diagnostics
        15.2.2. Research Use
   15.3. Market Size (US$ Mn) Forecast By Applications, 2017–2025
        15.3.1. Molecular Diagnostics
        15.3.2. Research Use
   15.4. Market Attractiveness Analysis By Applications

16. Global Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
   16.1. Market Size and Y-o-Y Growth
   16.2. Absolute $ Opportunity


List of Tables

Table 1: North America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 2: North America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Product Type
Table 3: North America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 4: North America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Applications
Table 5: Latin America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 6: Latin America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Product Type
Table 7: Latin America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 8: Latin America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 9: Europe Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 10: Europe Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 11: Europe Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 12: Europe Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Applications
Table 13: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 14: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 15: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 16: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Applications
Table 17: MEA Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 18: MEA Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product
Table 19: MEA Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 20: MEA Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Applications
Table 21: Global Human Papillomavirus (HPV) Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region, 
Table 22: Global Human Papillomavirus (HPV) Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Product, 
Table 23: Global Human Papillomavirus (HPV) Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By End User, 
Table 24: Global Human Papillomavirus (HPV) Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By End User, 


List of Figures

Figure 1: North America HPV Testing Market Value Share By Product 
Figure 2: North America HPV Testing Market Value Share By End User 
Figure 3: North America HPV Testing Market Value Share By Applications 
Figure 4: North America HPV Testing Market Value Share By Country
Figure 5: North America Human Papillomavirus (HPV) Testing Market Size Analysis, 2012–2016
Figure 6: North America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 7: North America Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025 
Figure 8: North America Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 9: U.S. Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 10: Canada Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 11: North America HPV Testing Market Attractiveness Analysis, By Product
Figure 12: North America HPV Testing Market Attractiveness Analysis, By End User
Figure 13: North America HPV Testing Market Attractiveness Analysis, By Application
Figure 14: North America HPV Testing Market Attractiveness Analysis, By Region
Figure 15: Latin America HPV Testing Market Value Share By Product  
Figure 16: Latin America HPV Testing Market Value Share By End User  
Figure 17: Latin America HPV Testing Market Value Share By Applications  
Figure 18: Latin America HPV Testing Market Value Share By Country  
Figure 19: Latin America Human Papillomavirus (HPV) Testing Market Size Analysis, 2012–2016
Figure 20: Latin America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 21: Latin America Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025 
Figure 22: Latin America Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 23: Brazil Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 24: Mexico Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 25: Argentina Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 26: Rest of Latin America Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 27: Latin America HPV Testing Market Attractiveness Analysis, By Product
Figure 28: Latin America HPV Testing Market Attractiveness Analysis, By End User
Figure 29: Latin America HPV Testing Market Attractiveness Analysis, By Application
Figure 30: Latin America HPV Testing Market Attractiveness Analysis, By Region
Figure 31: Europe HPV Testing Market Value Share By Product  
Figure 32: Europe HPV Testing Market Value Share By End User  
Figure 33: Europe HPV Testing Market Value Share By Applications  
Figure 34: Europe HPV Testing Market Value Share By Country  
Figure 35: Europe Human Papillomavirus (HPV) Testing Market Size Analysis, 2012–2016
Figure 36: Europe Human Papillomavirus (HPV) Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 37: Europe Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025 
Figure 38: Europe Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 39: Germany Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 40: France Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 41: Russia Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 42: Italy Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 43: Spain Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 44: U.K. Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 45: Netherlands Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 46: Rest of Europe Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 47: Europe HPV Testing Market Attractiveness Analysis, By Product
Figure 48: Europe HPV Testing Market Attractiveness Analysis, By End User
Figure 49: Europe HPV Testing Market Attractiveness Analysis, By Application
Figure 50: Europe HPV Testing Market Attractiveness Analysis, By Region
Figure 51: Asia Pacific HPV Testing Market Value Share By Product  
Figure 52: Asia Pacific HPV Testing Market Value Share By End User  
Figure 53: Asia Pacific HPV Testing Market Value Share By Applications  
Figure 54: Asia Pacific HPV Testing Market Value Share By Country  
Figure 55: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size Analysis, 2012–2016
Figure 56: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 57: Asia-Pacific Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025 
Figure 58: Asia-Pacific Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 59: China Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 60: India Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 61: Japan Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 62: Australia & New Zealand HPV Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 63: Rest of Asia Pacific HPV Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 64: Asia Pacific HPV Testing Market Attractiveness Analysis, By Product
Figure 65: Asia Pacific HPV Testing Market Attractiveness Analysis, By End User
Figure 66: Asia Pacific HPV Testing Market Attractiveness Analysis, By Application
Figure 67: Asia Pacific HPV Testing Market Attractiveness Analysis, By Region
Figure 68: Middle East & Africa HPV Testing Market Value Share By Product  
Figure 69: Middle East & Africa HPV Testing Market Value Share By End User  
Figure 70: Middle East & Africa HPV Testing Market Value Share By Applications  
Figure 71: Middle East & Africa HPV Testing Market Value Share By Country  
Figure 72: MEA Human Papillomavirus (HPV) Testing Market Size Analysis, 2012–2016
Figure 73: MEA Human Papillomavirus (HPV) Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 74: MEA Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025
Figure 75: MEA Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 76: GCC Countries Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 77: South Africa Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 78: Turkey Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 79: Rest of MEA Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 80: MEA HPV Testing Market Attractiveness Analysis, By Product
Figure 81: MEA HPV Testing Market Attractiveness Analysis, By End User
Figure 82: MEA HPV Testing Market Attractiveness Analysis, By Application
Figure 83: MEA HPV Testing Market Attractiveness Analysis, By Region
Figure 84: Global Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025
Figure 85: Global Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 86: Global Human Papillomavirus (HPV) Testing Market Attractiveness Analysis By Region, 2017–2025
Figure 87: Global Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Product, 2017 & 2025
Figure 88: Global Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Product, 2016–2025
Figure 89: Global Human Papillomavirus (HPV) Testing Market Attractiveness Analysis By Product Type, 2017–2025
Figure 90: Global Human Papillomavirus (HPV) Testing Market Share Analysis (%) By End User, 2017 & 2025
Figure 91: Global Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By End User, 2016–2025
Figure 92: Global Human Papillomavirus (HPV) Testing Market Attractiveness Analysis By End User, 2017–2025
Figure 93: Global Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Applications, 2017 & 2025
Figure 94: Global Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Applications, 2016–2025
Figure 95: Global Human Papillomavirus (HPV) Testing Market Attractiveness Analysis By End User, 2017–2025
Figure 96: Global Human Papillomavirus (HPV) Testing Market Value Analysis and Forecast, 2016–2025 (US$ Mn)
Figure 97: Global Human Papillomavirus (HPV) Testing Market Absolute $ Opportunity (US$ Mn), 2012–2016
Figure 98: Global Human Papillomavirus (HPV) Testing Market Absolute $ Opportunity (US$ Mn), 2016–2025